Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficiency of Baracetinib to Induce Remission of Active Lupus Nephritis

NCT05432531 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05432531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05432531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficiency of Baracetinib to Induce Remission of Active Lupus Nephritis
Lead sponsor
Assiut University
Phase
Phase 3
Overall status
Unknown status
Start date
June 1, 2022
Completion date
April 1, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis